Observational studyPloS one2026
Activated charcoal filtration profoundly alters systemic noradrenaline concentrations during hepatic chemosaturation: A prospective cohort study.
Observational study in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatic chemosaturation using extracorporeal circulation (ECC) is associated with severe hemodynamic instability. Activated charcoal filters are used to prevent systemic toxicity, but their effects on circulating catecholamines remain poorly understood.
methodsIn this prospective, single-center observational study, systemic catecholamine concentrations were measured in 15 procedures undergoing hepatic chemosaturation. Blood samples were obtained at predefined time points: after induction of anesthesia (T0), during initiation of ECC (T1), immediately before (T2.1) and after charcoal filtration (T2.2) and after termination of ECC (T3).
resultsSystemic noradrenaline concentrations changed significantly over time (p < 0.001). The measured noradrenaline concentration increased markedly during inferior vena cava occlusion and ECC. This was consistent with pronounced hemodynamic instability and a significant increase in the dose of noradrenaline administered (T1 and T2.1 vs. T0), followed by a near-complete reduction across the activated charcoal filter (median extraction rate 95.5%) with continued high NA administration (median 0.35 µg/kg/min). In contrast, adrenaline and dopamine concentrations remained stable and were neither administered nor significantly affected by filtration. After termination of ECC, a pronounced rebound increase in noradrenaline concentrations was observed. These biochemical changes were accompanied by metabolic acidosis and rising lactate levels.
conclusionActivated charcoal filtration during hepatic chemosaturation selectively removes circulating noradrenaline and is a key contributor to perioperative hemodynamic instability. Awareness of this mechanism is essential for tailored vasopressor strategies and safer anesthetic management.
trial registrationDRKS, DRKS00034527. Registered 24 June 2024, https://drks.de/search/de/trial/DRKS00034527.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.